|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 47, 260-267, February 2006 Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B
* Lipid Biology in Health and Disease Research Group, Children's Hospital Oakland Research Institute, Oakland, CA 94609 Published, JLR Papers in Press, November 28, 2005.
1 To whom correspondence should be addressed. e-mail: rryan{at}chori.org
The polyene antibiotic amphotericin B (AMB) is an effective antifungal agent whose therapeutic potential is limited by poor aqueous solubility and toxicity toward host tissues. Addition of apolipoprotein A-I to a multilamellar phospholipid vesicle dispersion containing 20% (w/w) AMB induces the formation of reconstituted high density lipoprotein (rHDL), with solubilization of the antibiotic. Density gradient ultracentrifugation resulted in flotation of the complexes to a density of 1.16 g/ml, and negative stain electron microscopy revealed a population of disk-shaped particles. Native gradient polyacrylamide gel electrophoresis indicated a particle diameter of
Supplementary key words apolipoprotein phospholipid Saccharomyces cerevisiae fungus Candida albicans red blood cell drug delivery density gradient ultracentrifugation electron microscopy Abbreviations: AMB, amphotericin B; apoA-I, apolipoprotein A-I; DMPC, dimyristoylphosphatidylcholine; DMPG, dimyristoylphosphatidylglycerol; IC90, concentration at which 90% growth inhibition occurs; RBC, red blood cell; rHDL, reconstituted high density lipoprotein; YEPD, yeast extract peptone glucose broth medium
This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||